iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by Nvwm LLC

Nvwm LLC grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 96.4% during the 4th quarter, Holdings Channel reports. The firm owned 1,493 shares of the financial services provider’s stock after purchasing an additional 733 shares during the quarter. Nvwm LLC’s holdings in iShares Biotechnology ETF were worth $197,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $30,000. HHM Wealth Advisors LLC lifted its position in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth $36,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at $34,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 2.5 %

Shares of IBB opened at $142.33 on Thursday. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The stock has a fifty day simple moving average of $136.31 and a two-hundred day simple moving average of $141.47.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.